CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 113 enrolled
Drug / intervention
Modified BreathIDdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01650831
NCT01650831N/ACompleted
CompareCT.gov

Clinical Study to Evaluate the Equivalence of the Modified BreathID Compared to Currently Approved BreathID System in Detection of H.Pylori Infection

Meridian Bioscience, Inc.·interventional·Posted Jul 26, 2012·Updated Dec 20, 2022

In Brief

A clinical study evaluating Modified BreathID for Suspicion of Being Infected With H.Pylori. Completed, enrolled 113 participants across 1 site.

Detailed Summary

The purpose of this study is to confirm equivalence of a new generation breath analyzer (Modified BreathID) in its ability to detect H. pylori compared to the currently approved BreathID® System.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSuspicion of Being Infected With H.Pylori
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 26, 2012
Enrollment StartOct 1, 2012
Primary CompletionNov 1, 2012
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 13.9 years ago

Interventions

Modified BreathIDdevice

A new modified device, compared to the originally cleared BreathID measures breath from a subject via a nasal cannula